探索陶胺,酸胆和COPD患病率和发病率之间的关联:FINRISK基于人口的队列研究
Mohammadreza Shoghli1, Juha Sinisalo2, A Inkeri Lokki3,2
1Department of Population Health, University of Helsinki, Helsinki, 00014, Finland.
BMC pulmonary medicine
|October 15, 2025
概括
脂质生物标志物,特别是胺 (Cers) 和酸胆 (PC),与慢性阻塞性肺病 (COPD) 风险有关. 由胺比率得出的CERT得分高,显著预测了COPD的流行和发病情况,特别是在吸烟者中.
科学领域:
- 利皮多米克 (Lipidomics) 是一种消化剂.
- 肺部医学 肺部医学
- 生物标志物发现发现
背景情况:
- 陶胺 (Cers) 和甲 (PC) 涉及慢性阻塞性肺病 (COPD) 病原,与炎症和脂质失调有关.
- 然而,在以人口为基础的研究中,它们对COPD患病率和发病率的具体影响仍未得到充分研究,特别是在性别特异性影响和吸烟方面.
- 这项研究通过调查Cers,PC和COPD风险之间的相互作用来解决这些知识差距.
研究的目的:
- 调查陶胺 (Cers),酸胆 (PCs) 和心血管事件风险测试 (CERT) 分数与COPD的患病率和发病率之间的关联.
- 探索潜在的性别差异以及吸烟对这些关联的影响.
- 评估脂质生物标志物对COPD风险预测的有用性.
主要方法:
- 使用基于人口的FINRISK 2002队列 (N=7,722用于流行率,N=7,662用于发病率) 的观察性研究.
- 后勤回归模型评估了脂质生物标志物和流行COPD之间的关联; 考克斯回归模型评估了发生的COPD.
- 心血管事件风险测试 (CERT) 1和2分数,来自胺比率,分析了它们与COPD风险的关联,通过使用卡普兰-梅尔曲线对吸烟状况进行分层分析.
主要成果:
- 升高的CERT1和CERT2得分与流行和发生的COPD显著相关.
- 一种特定的酸丁胆物种 (14:0/22:6) 与发生COPD的风险降低有显著的关联.
- 一种特定的陶胺与酸胆的比率 (Cer 18:1/18:0) /PC 14:0/22:6) 与患有流行和发作COPD的风险增加有关.
- 吸烟者表现出较高的COPD风险,随着CERT分数的增加.
结论:
- 脂质生物标志物,特别是胺和CERT评分,在COPD风险中发挥着重要作用.
- 这些发现支持使用脂质生物标志物来增强COPD风险预测和管理策略.
- 针对吸烟者的有针对性的干预措施可能会从纳入这些基于脂质的风险评估中受益.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K